Figure 1 from Phase Ib Study of Immunocytokine Simlukafusp Alfa (FAP-IL2v) Combined with Pembrolizumab for Treatment of Advanced and/or Metastatic Melanoma
Authors:
- Eva Munoz-CouseloEMEva Munoz-Couselo
- Ainara Soria RivasARAinara Soria Rivas
- Shahneen SandhuShahneen Sandhu
- Georgina V. LongGLGeorgina V. Long
- Miguel F. SanmamedMSMiguel F. Sanmamed
- Anna SpreaficoASAnna Spreafico
- Elizabeth BuchbinderEBElizabeth Buchbinder
- Mario SznolMSMario Sznol
- Hans PrenenHPHans Prenen
- Alexander FedenkoAFAlexander Fedenko
- Mohammed MilhemMohammed Milhem
- Ana Maria Arance FernandezAFAna Maria Arance Fernandez
Open Access
- 24 February 2025
- other
- Published by American Association for Cancer Research (AACR)